Where Gut Peptide Hormones Are Produced

Gut peptide hormones are produced by specialized endocrine and enteroendocrine cells distributed across the stomach, small intestine, and large intestine. Different peptides show different regional patterns, and some are also produced outside the gastrointestinal tract. A peptide’s gastrointestinal association therefore does not mean that it comes from one cell type or one anatomical location.

Regional peptide production is an important part of the broader biological framework described in Gut Peptides: Enteroendocrine Cells, Nutrient Sensing, Signaling, and Research Interpretation. Research examines which cells contain particular peptide precursors, where those cells occur, how precursor processing differs, and how peptide release changes under defined experimental conditions.

Research-use notice: InStrips products are offered for research and analytical use only. They are not intended to diagnose, treat, cure, or prevent any disease, injury, deficiency, absorption disorder, digestive condition, or medical condition.

Information about where an endogenous gut peptide is produced should not be interpreted as evidence that an externally supplied peptide, supplement, oral strip, injection, or other formulation reproduces the same cellular signaling.

Production Is Distributed Across the Gastrointestinal Tract

The gastrointestinal endocrine system is distributed rather than concentrated within one endocrine gland.

Peptide-producing cells occur in regions including:

• stomach
• duodenum
• jejunum
• ileum
• colon
• rectal regions

The number and type of hormone-expressing cells differ between these locations.

Regional Distribution Is Not Uniform

A gut peptide may be more strongly associated with one gastrointestinal region while still being detectable elsewhere.

Regional patterns can differ in:

• cell density
• hormone expression
• precursor expression
• nutrient-sensor expression
• receptor expression
• release characteristics

Statements such as “produced in the intestine” can therefore be too broad for detailed research interpretation.

Enteroendocrine Cells Are Major Sources

Many intestinal peptide hormones are produced by enteroendocrine cells embedded within the gastrointestinal epithelium.

These cells can contain:

• peptide precursors
• processing enzymes
• secretory granules
• nutrient receptors
• transporters
• intracellular signaling machinery

The combination varies among enteroendocrine-cell populations.

Stomach Endocrine Cells

The stomach contains several specialized endocrine populations associated with different peptide signals.

Frequently studied examples include cells associated with:

• gastrin
• ghrelin
• somatostatin

These cell populations occupy different gastric regions and respond to different local and neural signals.

Gastrin-Producing Cells

Gastrin is associated primarily with G cells located prominently in the gastric antral region and proximal gastrointestinal tract.

Research on gastrin-producing cells may examine:

• cell localization
• gastrin precursor processing
• luminal signals
• neural inputs
• local inhibitory signals
• different molecular gastrin forms

The term gastrin itself can represent more than one processed molecular form.

Ghrelin-Producing Cells

Ghrelin is strongly associated with specialized endocrine cells in the stomach, particularly within the gastric mucosa.

Research may distinguish:

• ghrelin gene expression
• ghrelin precursor processing
• acylated ghrelin
• des-acyl forms
• regional cell abundance
• circulating peptide measurements

Measurement of total ghrelin and measurement of a selected molecular form are not necessarily equivalent.

Somatostatin-Producing Cells

Somatostatin-producing D cells occur in the stomach and intestinal tract as well as other tissues.

Research may examine their relationships with:

• neighboring endocrine cells
• gastric epithelial cells
• neural signals
• luminal chemistry
• local regulatory networks

This illustrates why gastrointestinal peptide production can involve local paracrine relationships in addition to circulating signals.

The Duodenum Contains Diverse Endocrine Populations

The duodenum is exposed early to gastric contents, pancreatic secretions, bile, and digestion products.

Enteroendocrine populations in this region include cells associated with:

• CCK
• GIP
• secretin
• somatostatin
• other coexpressed peptide signals

The abundance of particular peptide transcripts and cells changes further along the intestine.

CCK-Associated Cells

Cholecystokinin is strongly associated with enteroendocrine populations of the proximal small intestine.

Historically these were called I cells.

Research may investigate responses to:

• fatty acids
• protein digestion products
• amino acids
• luminal nutrient mixtures

Modern studies show that CCK-expressing cells can also express other gastrointestinal hormones.

GIP-Associated Cells

Glucose-dependent insulinotropic polypeptide is strongly associated with K cells in the proximal small intestine.

Research examines:

• cell distribution
• glucose sensing
• lipid sensing
• GIP gene expression
• secretory granules
• coexpression with other hormones

K-cell terminology remains useful but does not capture all observed cell heterogeneity.

Secretin-Associated Cells

Secretin is associated with S cells located prominently in the proximal small intestine.

Experimental questions can involve:

• luminal acidity
• regional expression
• cellular activation
• peptide release
• coexpression with other enteroendocrine markers

The older S-cell label describes a predominant hormone rather than necessarily an exclusive peptide identity.

The Jejunum Contains Overlapping Cell Populations

The jejunum contains endocrine cells associated with several gut peptides rather than one dominant hormone system.

Studies have reported expression involving:

• CCK
• GIP
• secretin
• GLP-related peptides
• PYY
• neurotensin

The relative expression of these signals changes along the intestinal axis.

The Ileum Has a Different Hormonal Profile

More distal small-intestinal regions contain increased representation of selected enteroendocrine populations commonly associated with L-cell biology.

Frequently studied peptides include:

• GLP-1
• GLP-2
• PYY
• oxyntomodulin
• neurotensin

These peptides may be coexpressed within overlapping cell populations.

L Cells Are Not Defined by Only One Hormone

L cells were historically associated mainly with glucagon-like peptides and PYY.

Modern molecular studies demonstrate expression of multiple products within individual L-cell populations.

Depending on region and model, an L cell may contain:

• proglucagon-derived peptides
• PYY
• neurotensin
• CCK-related transcripts
• other endocrine markers

This makes the older one-cell, one-hormone framework incomplete.

GLP-1 Production

GLP-1 is generated from the proglucagon precursor through tissue-specific processing.

Research may distinguish:

• proglucagon expression
• processing enzymes
• mature GLP-1 forms
• intracellular storage
• released peptide
• circulating peptide metabolites

Measuring one stage of this pathway does not measure all stages.

GLP-2 Production

GLP-2 is also derived from the proglucagon precursor in intestinal endocrine cells.

Its presence illustrates how one precursor can generate multiple peptide products.

Research may examine:

• proglucagon processing
• regional L-cell abundance
• co-release with other proglucagon products
• peptide degradation
• assay specificity

Oxyntomodulin Production

Oxyntomodulin is another proglucagon-derived peptide generated through intestinal precursor processing.

It can therefore occur within the same broad endocrine-cell populations that produce GLP-related peptides.

This illustrates why:

• one gene can encode multiple peptide products
• one cell can contain several processed peptides
• one stimulus can alter several peptide measurements

PYY Production

Peptide YY is strongly associated with enteroendocrine populations in distal small-intestinal and colonic regions.

Research may distinguish:

• PYY precursor expression
• intracellular peptide
• released PYY
• processed molecular forms
• regional differences

The molecular form measured should be identified where possible.

Neurotensin-Producing Cells

Neurotensin is associated with selected enteroendocrine populations, particularly within portions of the small intestine.

Modern molecular studies have shown overlap between neurotensin-expressing cells and other enteroendocrine hormone profiles.

Research may examine:

• regional expression
• nutrient responsiveness
• coexpression
• cell lineage
• peptide release

The Colon Contains Important Peptide-Producing Cells

The colon contains enteroendocrine populations adapted to a luminal environment that differs substantially from the proximal small intestine.

Commonly investigated signals include:

• PYY
• GLP-1
• GLP-2
• somatostatin
• other regionally expressed peptides

These cells are exposed to substantial concentrations of microbial metabolites.

Microbial Metabolites and Colonic Cells

Colonic enteroendocrine cells can express receptors responsive to metabolites produced by intestinal microorganisms.

Research may investigate:

• short-chain fatty acids
• secondary bile acids
• tryptophan-related metabolites
• other fermentation products

Microbial signaling is one factor that distinguishes the colonic environment from more proximal intestinal regions.

Production and Release Are Different Measurements

Detecting peptide RNA or intracellular peptide does not establish that the peptide has been secreted.

Researchers may separately measure:

• gene transcription
• prohormone abundance
• mature intracellular peptide
• secretory granules
• released peptide
• circulating peptide

These endpoints describe different stages of peptide biology.

RNA Expression Does Not Equal Peptide Concentration

Single-cell RNA sequencing and related techniques identify messenger RNA associated with peptide production.

RNA abundance can differ from peptide abundance because of:

• translation rates
• precursor processing
• peptide storage
• secretion
• degradation

Transcriptomic and peptide measurements should therefore not be treated as interchangeable.

Preprohormones and Prohormones

Many gut hormones begin as larger precursor molecules.

Production may involve:

• gene transcription
• translation of a preprohormone
• removal of signal sequences
• prohormone formation
• proteolytic cleavage
• terminal modification

The mature peptide may represent only one product of the precursor.

Prohormone Convertases

Prohormone convertases contribute to cell-specific processing of peptide precursors.

Differences in processing enzymes can affect:

• which peptide products are generated
• their relative abundance
• which intermediates remain detectable
• how tissue-specific processing differs

The same precursor can therefore generate different products in different cell types.

Secretory Granules

Mature gut peptides are frequently stored in intracellular secretory granules before release.

Granule studies may investigate:

• peptide localization
• co-storage of different hormones
• granule maturation
• vesicle movement
• stimulus-dependent exocytosis

Co-storage does not necessarily establish identical release kinetics.

One Cell Can Produce Several Peptides

Modern enteroendocrine research has shown that many cells do not follow a strict one-cell, one-hormone pattern.

An individual cell may express several peptide products because of:

• shared lineage programs
• regional identity
• multiple hormone genes
• precursor processing
• cell maturation

This is one reason gut peptides cannot be assigned to completely separate cellular boxes.

One Peptide Can Have More Than One Tissue Source

Some peptides associated with the gastrointestinal tract can also be expressed in tissues outside the gut.

Possible extraintestinal sources may include:

• pancreatic cells
• neuronal populations
• endocrine tissues
• other specialized cells

The importance of those sources depends on the peptide and research question.

Local Production and Circulating Concentration Are Different

A tissue can produce a peptide without generating a proportionally large circulating signal.

Circulating measurements are influenced by:

• release amount
• local receptor binding
• blood flow
• enzymatic degradation
• organ clearance
• sample timing

Blood concentration therefore does not provide a simple map of tissue production.

Regional Venous Sampling

Some studies use blood collected from vessels draining specific gastrointestinal regions to investigate peptide release.

This approach may provide information different from peripheral blood because peptide concentrations can change during:

• circulation
• enzymatic processing
• organ passage
• dilution

Sampling location should be reported when results are compared.

Immunohistochemistry

Antibody-based staining can identify peptide-containing cells within gastrointestinal tissue.

Interpretation depends on:

• antibody specificity
• epitope recognition
• tissue fixation
• signal threshold
• cross-reactivity

Staining demonstrates detectable antigen in a location but does not quantify secretion directly.

In Situ Hybridization

In situ hybridization can identify cells containing RNA associated with hormone genes.

This can help map:

• regional expression
• cellular localization
• coexpression
• developmental differences

RNA detection remains distinct from mature peptide measurement.

Single-Cell Sequencing

Single-cell transcriptomic approaches have revealed extensive heterogeneity among enteroendocrine cells.

They can identify:

• multiple hormone transcripts in one cell
• regional subpopulations
• nutrient receptors
• developmental states
• lineage relationships

These findings have challenged rigid historical cell classifications.

Proteomic Approaches

Mass-spectrometry-based methods can identify peptide products and processing forms directly.

Research may investigate:

• peptide sequence
• precursor-derived fragments
• post-translational modifications
• relative abundance
• coexisting peptide species

Analytical sensitivity can limit detection of low-abundance gut hormones.

Organoid Models

Human and animal intestinal organoids can generate enteroendocrine populations in a controlled experimental environment.

Researchers may study:

• regional cell identity
• hormone expression
• cell differentiation
• nutrient responses
• gene function

Organoid production patterns should not automatically be treated as identical to intact gastrointestinal tissue.

Species Differences

The regional distribution of enteroendocrine cells is broadly conserved in many mammals but is not identical across species.

Differences may involve:

• cell abundance
• hormone coexpression
• intestinal length
• regional anatomy
• diet
• microbial environment

Species should remain explicit when tissue distribution is described.

Development and Age

Enteroendocrine populations can change during development and maturation.

Research may compare:

• fetal tissue
• neonatal tissue
• adult tissue
• aged tissue

Cell distribution observed at one developmental stage may not represent another.

Diet and Environment Can Influence Cell Populations

Longer-term nutritional and environmental conditions may affect enteroendocrine-cell abundance or gene expression.

Research variables can include:

• diet composition
• energy intake
• microbial composition
• intestinal inflammation
• experimental housing

These effects should be distinguished from immediate peptide release after a nutrient stimulus.

Why Production Site Does Not Define Biological Role

Knowing where a peptide is produced does not by itself establish what happens after release.

A complete signaling question can require investigation of:

• release stimulus
• molecular form
• receptor location
• local degradation
• neural pathways
• circulating concentrations

Production location is only one part of the pathway.

Why Production Site Does Not Define a Product

The fact that an endogenous peptide is produced in a particular gastrointestinal cell does not identify the properties of a manufactured peptide preparation.

Endogenous and manufactured materials may differ in:

• molecular form
• concentration
• release pattern
• formulation
• route
• distribution

Cellular physiology should not be converted into a product claim.

Relationship to Gut-Peptide Diversity

The regional and cellular distribution of gut hormones helps explain why the term gut peptides combines several distinct signaling systems rather than one uniform biological category.

This distinction is examined further in Why Gut Peptides Are Not One Biological Category.

Reading Regional Enteroendocrine Research

The open-access study A Major Lineage of Enteroendocrine Cells Coexpress CCK, Secretin, GIP, GLP-1, PYY, and Neurotensin but Not Somatostatin demonstrates regional differences and extensive hormone coexpression among enteroendocrine populations.

The study should be interpreted as evidence about enteroendocrine-cell identity and hormone expression rather than as evidence about external peptide products or personal use.

Final Perspective

Gut peptide hormones are produced by heterogeneous endocrine and enteroendocrine cell populations distributed from the stomach through the colon.

Different regions contain different combinations of gastrin, ghrelin, CCK, GIP, secretin, GLP-related peptides, PYY, neurotensin, somatostatin, and other signaling molecules, and individual cells may produce more than one peptide.

Accurate research-only coverage should identify the peptide, precursor, cell type, gastrointestinal region, processing pathway, experimental model, and measurement method without treating endogenous peptide production as evidence that a supplement, oral strip, injection, or other peptide product is beneficial or effective.